Mandal Ayan S, Shinohara Russell T, Jung Benjamin, Gardner Margaret, Akouri Habib E, Yerys Benjamin E, Guthrie Whitney, Janke Kelly M, Herrington John D, Hocking Matthew C, Ball Gareth, Payne Jonathan M, North Kathryn N, Muhlert Nils, Garg Shruti, Seidlitz Jakob, Fisher Michael J, Alexander-Bloch Aaron
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Child and Adolescent Psychiatry and Behavioral Science, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
medRxiv. 2025 Jun 23:2025.06.23.25328558. doi: 10.1101/2025.06.23.25328558.
Macrocephaly is among the most common findings in neurofibromatosis type 1 (NF1) and may be associated with other clinical manifestations of the genetic syndrome. NF1-specific growth charts that account for expected macrocephaly may increase sensitivity to detect atypical growth. We aimed to produce NF1-specific growth charts of head circumference for the age range of 0 to 3 years and to assess their potential clinical impact.
Using electronic health records from the Children's Hospital of Philadelphia, we collected head circumference measurements from children with NF1 and a community control cohort seen at scheduled well-child visits. We compared head circumference normed using Center for Disease Control (CDC) growth charts between these groups over time. We constructed NF1-specific growth charts using two independent methods. Finally, we used mixed-effects models to relate the resulting centile scores with developmental delay assessed with the Survey of Well-being of Young Children.
Our dataset contained 2180 observations from 305 individuals (167 male) with NF1, and 104,750 observations from 16,742 individuals (8809 male) in the community control cohort, all aged 0 to 3 years old. Head circumference was significantly elevated in NF1 throughout the age range ( <0.05), but the effect sizes varied nonlinearly with age, starting moderate at 1 month ( = 0.56), then small at four months ( = 0.28), moderate again at 15 months ( = 0.58), and finally large at 28 months ( = 0.8). NF1-specific growth curves demonstrated slower rate-of-growth for head circumference in the first two months of life yet more sustained growth over time. Although none of the children with NF1 met the standard for microcephaly according to CDC charts, smaller head circumference benchmarked against NF1-specific charts was correlated with developmental delay (standardized beta = 0.24; = 0.013).
We present the first NF1-specific growth charts for head circumference covering ages 0 to 3 years. Macrocephaly in NF1 becomes more exaggerated over time as rate-of-growth is sustained compared to controls. Smaller head size relative to NF1 growth expectations is not captured by CDC charts yet nevertheless relates to developmental delay, suggesting that NF1-specific charts may increase sensitivity to clinically concerning patterns of growth in children with NF1.
巨头畸形是1型神经纤维瘤病(NF1)最常见的表现之一,可能与该遗传综合征的其他临床表现相关。考虑到预期巨头畸形的NF1特异性生长图表可能会提高检测异常生长的敏感性。我们旨在制作0至3岁年龄段的NF1特异性头围生长图表,并评估其潜在的临床影响。
利用费城儿童医院的电子健康记录,我们收集了NF1患儿以及在定期健康儿童检查中就诊的社区对照队列儿童的头围测量数据。我们比较了随着时间推移,使用疾病控制中心(CDC)生长图表对这些组进行标准化后的头围。我们使用两种独立方法构建了NF1特异性生长图表。最后,我们使用混合效应模型将所得的百分位数分数与通过幼儿幸福感调查评估的发育迟缓相关联。
我们的数据集中包含来自305名个体(167名男性)的2180条NF1观察数据,以及来自社区对照队列中16742名个体(8809名男性)的104750条观察数据,所有个体年龄均在0至3岁之间。在整个年龄范围内,NF1患儿的头围均显著升高(<0.05),但效应大小随年龄呈非线性变化,1个月时中等(=0.56),4个月时较小(=0.28),15个月时再次中等(=0.58),最后在28个月时较大(=0.8)。NF1特异性生长曲线显示,在生命的前两个月头围生长速度较慢,但随着时间推移生长更持续。尽管根据CDC图表,没有NF1患儿符合小头畸形标准,但以NF1特异性图表为基准的较小头围与发育迟缓相关(标准化β=0.24;=0.013)。
我们展示了首个涵盖0至3岁年龄段的NF1特异性头围生长图表。与对照组相比,随着生长速度持续,NF1中的巨头畸形随时间变得更加明显。CDC图表未捕捉到相对于NF1生长预期的较小头围,但它仍与发育迟缓相关,这表明NF1特异性图表可能会提高对NF1患儿临床上令人担忧的生长模式的敏感性。